Risultati da 1 a 8 di 8

Discussione: CANILEISH BY VIRBAC VACCINO LEISHMANIOSI

  1. #1
    Senior Member

    User Info Menu

    CANILEISH BY VIRBAC VACCINO LEISHMANIOSI

    CANILEISH BY VIRBAC VACCINO LEISHMANIOSI

    DA QUI:

    http://www.virbac.com/p-vbcompuben/display.aspx?srv=p-vbcom&typ=pub&lang=en&cmd=view|list&style=styles/webnew.xsl&select=WEBNEW[@ID$eq$WEBNEW_44]|WEBNEW[fk_enum_THEME$eq$6]&order-by=-@ONDATE|-@ONDATE


    [u]VERRà LANCIATO IN ITALIA PER FINE ANNO...NEL FRATTEMPO MI INFORMO</u>

    Canine leishmaniosis: the CaniLeish® vaccine* obtains a European registration


    Carros - France, 17 March 2011

    Following submission of the registration dossier with the European Medicines Agency (EMA) in early 2010, the CVMP, Committee for Medicinal Products for Veterinary Use of the EMA, issued a favourable opinion on 13 January 2011 for CaniLeish®, the first vaccine against canine leishmaniosis in Europe. On 14 March, the European Commission confirmed this opinion by awarding Virbac a European registration for this vaccine.

    CaniLeish® will initially be launched in Portugal at the end of the first half of 2011. This will be followed rapidly by launches in other countries in the endemic area: Spain, France, Greece and Italy (not in chronological order). This roll-out takes account of the geographical prevalence of the disease and the time required to build vaccine production up to full capacity. The launch in Northern European countries from where there is a flow of summer visitors to the endemic area will be part of a second phase.

    * The CaniLeish® vaccine has been developed by BVT (Bio Véto Test), a 100% subsidiary of VIRBAC, in partnership with IRD (Institut de Recherche pour le Développement), and VIRBAC's R&D teams. This project is based on an invention patented by the IRD relating to leishmania culture, on which IRD has granted an exclusive patent licence to BVT for the veterinary market
    se tutti gli uomini avessero la capacità di amare che hanno i cani non ci sarebbero più crudeltà e non mi vergognerei più di far parte degli esseri umani

  2. #2
    Senior Member

    User Info Menu

    http://www.virbac.com


    Leishmaniosi canina: il vaccino CaniLeish ® * ottiene una registrazione europea

    Carros - Francia, 17 marzo 2011

    Dopo la presentazione del dossier di registrazione con l'European Medicines Agency (EMEA) all'inizio del 2010, il CMV, comitato per i medicinali per uso veterinario della EMA, ha espresso parere favorevole in data 13 gennaio 2011 per CaniLeish ®, il primo vaccino contro la leishmaniosi canina in Europa. Il 14 marzo, la Commissione europea ha confermato questo parere assegnando Virbac una registrazione europea per questo vaccino.

    CaniLeish ® sarà inizialmente lanciato in Portogallo alla fine del primo semestre del 2011. Questo sarà seguito rapidamente da lanci in altri paesi della zona endemica: Spagna, Francia, Grecia e Italia (non in ordine cronologico). Questo roll-out tiene conto della prevalenza geografica della malattia e il tempo necessario per costruire la produzione del vaccino fino a piena capacità. Il lancio in paesi del Nord Europa, da dove vi è un flusso di visitatori d'estate per l'area endemica sarà parte di una seconda fase.

    * Il vaccino CaniLeish ® è stato sviluppato da BVT (Bio Veto Test), una controllata al 100% di VIRBAC, in collaborazione con IRD (Institut de Recherche pour le Développement), e VIRBAC di R & S squadre. Questo progetto si basa su un'invenzione brevettata dalla IRD relative alla cultura leishmania, su cui IRD ha concesso un brevetto esclusivo di licenza per BVT per il mercato veterinario
    se tutti gli uomini avessero la capacità di amare che hanno i cani non ci sarebbero più crudeltà e non mi vergognerei più di far parte degli esseri umani

  3. #3
    Senior Member

    User Info Menu

    http://www.ema.europa.eu/docs/en_GB/...C500100745.pdf

    CaniLeish
    Leishmania infantum excreted secreted proteins (ESP)

    On 12 January 2011, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted a positive opinion,2 recommending the granting of a marketing authorisation for the veterinary medicinal product CaniLeish, a lyophilisate and solvent for suspension for injection, intended for the active immunisation of Leishmania negative dogs from 6 months of age to reduce the risk to develop an active infection and clinical disease after contact with Leishmania infantum. The applicant for this veterinary medicinal product is Virbac S.A.

    The active substance of CaniLeish is Leishmania infantum excreted secreted proteins (ESP).

    The benefits of CaniLeish are the stimulation of active immunity in Leishmania negative dogs from 6 months of age to reduce the risk to develop an active infection and clinical disease after contact with Leishmania infantum. The most common side effects are, moderate and transient local reactions that may occur after injection such as swelling, nodule, pain on palpation or erythema. These reactions resolve spontaneously within 2 to 15 days. Other transient signs commonly seen following vaccination may be observed such as hyperthermia, apathy and digestive disorders lasting 1 to 6 days. Allergic-type reactions are uncommon and appropriate symptomatic treatment should then be administered.

    The approved indication is:

    “For the active immunisation of Leishmania negative dogs from 6 months of age to reduce the risk to develop an active infection and clinical disease after contact with Leishmania infantum.

    The efficacy of the vaccine has been demonstrated in dogs submitted to multiple natural parasite exposure in zones with high infection pressure.

    Onset of immunity: 4 weeks after the primary vaccination course
    Duration of immunity: 1 year after the last (re-)vaccination”.

    Detailed conditions for the use of this product will be described in the summary of product characteristics (SPC) which will be published in the European public assessment report (EPAR) and will be available in all official European Union languages after the marketing authorisation has been granted by the European Commission.

    --------------------------------------------------------------------------------------------

    1 Summaries of opinion are published without prejudice to the Commission Decision, which will normally be issued within 90 days from adoption of the opinion.
    2 Applicants may appeal any CVMP opinion, provided they notify the European Medicines Agency in writing of their intention to appeal within 15 days of receipt of the opinion.
    The CVMP, on the basis of quality, safety and efficacy data submitted, considers that there is a favourable benefit to risk balance for CaniLeish and therefore recommends the granting of the marketing authorisation.
    se tutti gli uomini avessero la capacità di amare che hanno i cani non ci sarebbero più crudeltà e non mi vergognerei più di far parte degli esseri umani

  4. #4
    Senior Member

    User Info Menu

    Bene, magari funzionasse davvero

  5. #5
    Junior Member

    User Info Menu

    Regular client in this salon! I like everything very much! The staff is friendly, helpful and helpful! Beauticians are very good girls, smart, all procedures are done very high quality! I do everything in this salon: starting with cosmetology, ending with manicure and eyelash extensions! Highly recommend brooklyn spa!!! Come, you won't regret it!

  6. #6
    Junior Member

    User Info Menu

    I really liked the studio, the master made perfect eyelashes, took into account all my wishes in terms of length, bend. Comfortable chairs) Beautiful interior and cleanliness, you can always make an appointment, friendly administrator, pleasant music. I recommend Russian lip technique.

  7. #7
    Junior Member

    User Info Menu

    أفضل موقع سكس مجاني اون لاين xnxn
    افلام سكس عالية الدقة. موقع سكس آخر. معنا ، يمكنك الحصول على إصلاح إباحي بجودة مذهلة ، وبسهولة متدفقة إلى أي جهاز تملكه ، من الكمبيوتر اللوحي إلى الهاتف الذكي ، أو التلفزيون ذي الشاشة الكبيرة أو شاشة الكمبيوتر عالية الدقة. سكس حيوانات تتحول المواد الإباحية عالية الدقة شديدة الوضوح والحادة إلى وجهة نظرك المفضلة إلى تجربة ستجعلك تحبس أنفاسك وترغب في المزيد. xnxx هي طريقة جديدة لبث مقاطع الفيديو مجانًا ، باستخدام التكنولوجيا على نبض ذلك الوقت لمنحك أفضل تجربة إباحية عالية الدقة يمكنك الحصول عليها ، مع مشغل صخري صلب وبدون تلعثم. لدينا كل الأشياء الإباحية المثيرة التي تحبها لأننا نحرف أنفسنا ونعرف ما يريده عشاق الإباحية. كن مستعدًا لممارسة الجنس الشرجي بقوة حتى تشعر بالضغط على قضيبك سكس ، بينما تنتظر كتكوت آخر على ركبتيها لتذوقها في فمها. سكس اجنبي الخالية من العيوب بينما يأكلن كس بعضهن البعض. بغض النظر عن تفضيلاتك افلام سكس ، xnxx ءىءء ستجد أن الإباحية المتشددين شديدة بما يكفي لإشعال النار في شاشتك. سكس مصري هو المكان المناسب لمحبي الحمار الكبير والثدي وكذلك لخبراء الأجسام الصغيرة الرقيقة. نيك من فاتنة البهجة الأكثر إثارة إلى الفتاة الخجولة المجاورة ، سواء كانوا نجوم إباحيين مشهورين أو مجرد هواة بهاتف محمول أو ميلف جائعون أو مراهقين عديمي الخبرة يرتدون الزي المدرسي ، سكس مترجم سترى أجمل الفتيات في الإباحية عالية الدقة من جميع أنحاء العالم العالم يفعل أقذر الأشياء بدقة عالية. بورنو مهما كانت النكهة الإباحية التي تفضلها ، أينما كنت ، فقد قمنا بتغطيتك. تأتي المواد الإباحية عالية الدقة لدينا باللغة القوقازية الكلاسيكية أو إذا كنت تفضلها أكثر غرابة في الشرق أو الآسيوي ، بما في ذلك الإباحية اليابانية غير الخاضعة للرقابة ، لأننا لا نريدك أن تفوتك أي تفاصيل. نحن لا نخشى الخوض في مناطق أكثر قتامة مثل الهرات الأبنوس أو لاتينا أيضًا. سكس تأكد من إطلاعك على البرازيليين المشاكس. سكس عربي ، فنحن موقع إباحي متعدد اللغات. سكس عربي ، سكس اجنبي نحن نعتني برضاك ، عليك فقط التأكد من القيام بالجزء الخاطف. لأن سعادتك هي أجرنا. استمتع بالاباحية الخاصة بك HD ، عالي الدقة xnxx ، يقدم موقع سكس آلاف مقاطع الفيديو الإباحية بأعلى دقة HD سكس نار xnxx موقع افلام نيك هو المكان المناسب لك شاهد وحمل فيديو سكس اباحية عالية الدقة مجانا.

  8. #8
    Junior Member

    User Info Menu

    For a long time I did not dare to do permanent makeup, but a friend recommended Elite spa Newton MA. After the visit, I can note that it is safe, looks natural, emphasizes the shape and eliminates bald spots, the effect lasts 1-2 years, no need to tint, it healed quickly and without problems, it didn’t hurt me, everything is not as scary as they say about the procedure.

Discussioni Simili

  1. Vaccino Leishmaniosi
    Di Shane nel forum SALUTE, IGIENE & ALIMENTAZIONE
    Risposte: 46
    Ultimo Messaggio: 23-01-13, 08:38 AM
  2. Vaccino Leishmaniosi
    Di MatteM nel forum SALUTE, IGIENE & ALIMENTAZIONE
    Risposte: 1
    Ultimo Messaggio: 10-10-12, 02:39 PM
  3. vaccino leishmaniosi
    Di perdu nel forum SALUTE, IGIENE & ALIMENTAZIONE
    Risposte: 1
    Ultimo Messaggio: 23-02-08, 04:58 PM
  4. CERCASI INFO SPERIMENTAZIONE VACCINO LEISHMANIOSI
    Di Maira71 nel forum SALUTE, IGIENE & ALIMENTAZIONE
    Risposte: 4
    Ultimo Messaggio: 14-06-06, 09:40 PM
  5. LEISHMANIOSI, SPERIMENTAZIONE VACCINO
    Di francy_capo nel forum SALUTE, IGIENE & ALIMENTAZIONE
    Risposte: 2
    Ultimo Messaggio: 08-02-06, 10:14 PM

Permessi di Scrittura

  • Tu non puoi inviare nuove discussioni
  • Tu non puoi inviare risposte
  • Tu non puoi inviare allegati
  • Tu non puoi modificare i tuoi messaggi
  •